HomeCTKB • NASDAQ
add
Cytek Biosciences Inc
Previous close
$6.01
Day range
$5.88 - $6.55
Year range
$3.80 - $12.31
Market cap
836.15M USD
Avg Volume
696.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 58.23M | 20.48% |
Operating expense | 33.18M | 13.30% |
Net income | 5.50M | 64.51% |
Net profit margin | 9.45 | 36.56% |
Earnings per share | 0.08 | 10.88% |
EBITDA | 1.49M | 76.80% |
Effective tax rate | -33.86% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 262.41M | -23.08% |
Total assets | 494.46M | -4.82% |
Total liabilities | 101.39M | 7.95% |
Total equity | 393.06M | — |
Shares outstanding | 130.82M | — |
Price to book | 2.00 | — |
Return on assets | -0.07% | — |
Return on capital | -0.08% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 5.50M | 64.51% |
Cash from operations | 9.51M | 53.59% |
Cash from investing | 29.07M | 156.92% |
Cash from financing | -33.75M | -976.73% |
Net change in cash | 4.00M | 109.52% |
Free cash flow | 8.80M | 253.11% |
About
Founded
1992
Website
Employees
676